We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

24 hedge funds and large institutions have $4.72M invested in Filana Therapeutics in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

0.34% more ownership

Funds ownership: 32.92% → 33.26% (+0.34%)

8% less funds holding

Funds holding: 26 → 24 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

71% less capital invested

Capital invested by funds: $16.1M → $4.72M (-$11.4M)

Holders
24
Holders Change
-2
Holders Change %
-7.69%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$167K
2
BlackRock
BlackRock
New York
+$145K
3
ZIM
Zacks Investment Management
Illinois
+$97.5K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$81.8K
5
Northern Trust
Northern Trust
Illinois
+$33.5K

Top Sellers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
-$146K
2
Ameriprise
Ameriprise
Minnesota
-$80K
3
Morgan Stanley
Morgan Stanley
New York
-$53.6K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$24.9K
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$10.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
First Eagle Investment Management
1
First Eagle Investment Management
New York
$1.93M – – –
NCM
2
Nantahala Capital Management
Connecticut
$1.33M – – –
BlackRock
3
BlackRock
New York
$416K +$145K +16,858 +9%
Vanguard Group
4
Vanguard Group
Pennsylvania
$373K – – –
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$124K – – –
Northern Trust
6
Northern Trust
Illinois
$87K +$33.5K +3,902 +10%
Bank of New York Mellon
7
Bank of New York Mellon
New York
$81K -$10.7K -1,248 -3%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$77K +$81.8K +9,535 +34%
Renaissance Technologies
9
Renaissance Technologies
New York
$58K +$20.6K +2,400 +9%
BCM
10
Bridgeway Capital Management
Texas
$49K – – –
VF
11
Virtu Financial
New York
$40K +$167K +19,525 New
California Public Employees Retirement System
12
California Public Employees Retirement System
California
$29K – – –
JMPWA
13
JP Morgan Private Wealth Advisors
California
$28K – – –
D.E. Shaw & Co
14
D.E. Shaw & Co
New York
$26K -$24.9K -2,902 -19%
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$25K -$918 -107 -0.9%
ZIM
16
Zacks Investment Management
Illinois
$23K +$97.5K +11,373 New
UBS Group
17
UBS Group
Switzerland
$16K +$30.1K +3,506 +88%
Bank of America
18
Bank of America
North Carolina
$5K – – –
Morgan Stanley
19
Morgan Stanley
New York
$2K -$53.6K -6,246 -86%
Wells Fargo
20
Wells Fargo
California
$2K – – –
AG
21
Advisor Group
Arizona
$1K – – –
FANJ
22
Financial Architects (New Jersey)
New Jersey
$1K – – –
Deutsche Bank
23
Deutsche Bank
Germany
– -$146K -20,632 Closed
Ameriprise
24
Ameriprise
Minnesota
– -$80K -11,300 Closed
PCM
25
Poehling Capital Management
Wisconsin
– -$7K -1,000 Closed
1
2

FLNA Hedge Fund Activity: Q2 2018 in Review

24 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q2 2018, worth a combined $4.72M — down 71% from $16.1M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of FLNA and 2 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 5 added.

The largest buyer was Virtu Financial, opening a new position worth an estimated $167K. The largest seller was Deutsche Bank, exiting entirely with an estimated $146K sold.

  • 24 institutional investors held Filana Therapeutics (FLNA) as of Q2 2018, down from 26 in Q1 2018.
  • Funds reported $4.72M of Filana Therapeutics stock for Q2 2018, down 71% quarter-over-quarter.
  • 2 funds opened new Filana Therapeutics positions in Q2 2018 and 4 closed out, a net change of -2 holders.
  • The largest Filana Therapeutics buyer in Q2 2018 was Virtu Financial, an estimated $167K added.
  • The largest Filana Therapeutics seller in Q2 2018 was Deutsche Bank, an estimated $146K sold.

Based on aggregated 13F filings for Q2 2018.